Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Quinn Anthony G. Create: Alert

All | News | Filings
Date FiledTypeDescription
06/12/2023 4 Quinn Anthony G. (Director) has filed a Form 4 on Generation Bio Co.
Txns: Granted 25,000 options to buy @ $4.83, valued at $120.8k
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/18/2022 4 Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Bought 80,079 shares @ $2.344, valued at $187.7k
03/15/2022 4 Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Bought 34,777 shares @ $2.064, valued at $71.8k
Bought 67,472 shares @ $1.93, valued at $130.2k
Bought 42,417 shares @ $1.8611, valued at $78.9k
02/22/2022 4 Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 350,000 options to buy @ $3.17, valued at $1.1M
12/13/2021 4 Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Bought 43,108 shares @ $3.7, valued at $159.5k
Bought 10,526 shares @ $3.75, valued at $39.5k
10/29/2021 4 Quinn Anthony G. (Director) has filed a Form 4 on Generation Bio Co.
Txns: Gifted 72,837 shares @ $0
Gifted 72,837 shares @ $0
07/01/2021 4 Quinn Anthony G. (Director) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns: Granted 15,000 options to buy @ $7.44, valued at $111.6k
06/11/2021 4 Quinn Anthony G. (Director) has filed a Form 4 on Generation Bio Co.
Txns: Granted 15,000 options to buy @ $26.59, valued at $398.9k
02/19/2021 4 Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 330,000 options to buy @ $7.35, valued at $2.4M
07/01/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/18/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2020 4 Quinn Anthony G. (Director) has filed a Form 4 on Generation Bio Co.
Txns: Granted 52,000 options to buy @ $19, valued at $988k
06/11/2020 3 Quinn Anthony G. (Director) has filed a Form 3 on Generation Bio Co.
05/04/2020 4 Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Bought 165,000 shares @ $4.75, valued at $783.8k
02/19/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/07/2019 4 Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Exercised 662 options to buy @ $5.46, valued at $3.6k
Exercised 17,603 options to buy @ $6.31, valued at $111.1k
06/14/2019 4 Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Bought 12,217 shares @ $6.1148, valued at $74.7k
Bought 14,406 shares @ $6.1666, valued at $88.8k
Bought 5,282 shares @ $6.2311, valued at $32.9k
05/22/2019 4 Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Bought 8,989 shares @ $6.555, valued at $58.9k
Bought 13,794 shares @ $6.8857, valued at $95k
Bought 3,809 shares @ $6.8596, valued at $26.1k
05/17/2019 4 Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Bought 719 shares @ $7.098, valued at $5.1k
Bought 6,256 shares @ $6.7566, valued at $42.3k
Bought 5,520 shares @ $6.828, valued at $37.7k
Bought 6,218 shares @ $6.6477, valued at $41.3k
03/04/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/01/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/27/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
02/08/2019 4 Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Exercised 1,323 options to buy @ $5.46, valued at $7.2k
Exercised 7,433 options to buy @ $6.31, valued at $46.9k
12/10/2018 4 Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Bought 2,000 shares @ $6.02, valued at $12k
Bought 994 shares @ $9.13, valued at $9.1k
Exercised 150,000 options to buy @ $4.11, valued at $616.5k
Exercised 3,306 options to buy @ $5.46, valued at $18.1k
Exercised 18,584 options to buy @ $6.31, valued at $117.3k
07/20/2018 4 Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 300,000 options to buy @ $9.36, valued at $2.8M
Granted 75,000 options to buy @ $9.36, valued at $702k
Granted 50,000 options to buy @ $9.36, valued at $468k
07/16/2018 4 Quinn Anthony G. (Interim CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Exercised 24,000 options to buy @ $7.04, valued at $169k
Exercised 14,866 options to buy @ $6.31, valued at $93.8k
07/13/2018 4 Quinn Anthony G. (Interim CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Exercised 3,307 options to buy @ $5.46, valued at $18.1k
02/22/2018 4 Quinn Anthony G. (Interim CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 178,400 options to buy @ $6.31, valued at $1.1M
02/20/2018 4 Quinn Anthony G. (Interim CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Exercised 15,211 options to buy @ $5.46, valued at $83.1k
12/08/2017 4 Quinn Anthony G. (Interim CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Bought 4,888 shares @ $4.9248, valued at $24.1k
Bought 2,800 shares @ $4.9882, valued at $14k
Bought 600 shares @ $5.065, valued at $3k
12/05/2017 4 Quinn Anthony G. (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Bought 4,100 shares @ $4.5312, valued at $18.6k
Bought 7,956 shares @ $4.9804, valued at $39.6k
Bought 5,065 shares @ $4.931, valued at $25k
09/01/2017 4 Quinn Anthony G. (Interim CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 150,000 options to buy @ $4.11, valued at $616.5k
04/25/2017 4 Quinn Anthony (interim Chief Medical Officer) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy